Melbourne, United States
Violet Defense, founded in 2012 and headquartered in the United States, is committed to harnessing ultraviolet (UV) technology to fight against germs. With its proprietary solution, Violet Defense stands out in the Health Care, Manufacturing, Medical Devices, and Sports industries.
Its patented UV disinfection technology effectively targets and eliminates up to 99.9% of harmful pathogens such as E. coli, Salmonella, MRSA, C. diff., Norovirus, C. auris, and coronavirus. By being the only known Pulsed Xenon UV solution available for full-time room installation, the company creates a seamless and continuous disinfection process suited for diverse environments.
The company's most recent financial activity includes a $20.00M Series B investment in November 2021, with backing from prominent investors such as Kirenaga Partners and Katalyst Securities. This capital injection positions Violet Defense effectively to capitalize on the growing global concern for health and hygiene.
